
Pharmanutra
Researches and markets nutritional supplements & medical devices for all ages.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Established in 2003, PharmaNutra is a company specializing in the research, development, and marketing of nutritional supplements and medical devices. The firm emphasizes scientific innovation and manages the entire production process, from proprietary raw materials to finished goods. Through its in-house research centers and labs, it pioneers studies to create unique and effective products. The portfolio focuses on addressing nutritional deficiencies, such as minerals and vitamins, and supporting musculoskeletal and joint health for consumers of all ages.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Date | Filing | Language | Size | Actions | |
---|---|---|---|---|---|
2025-10-03 13:13 |
Transaction in Own Shares
Initiation of share buy-back program
|
English | 243.9 KB | ||
2025-10-03 13:12 |
Transaction in Own Shares
Avvio del programma di acquisti di azioni proprie
|
Italian | 232.8 KB | ||
2025-10-01 09:00 |
Investor Presentation
Eccellenze del Made in Italy | Presentazione
|
English | 5.0 MB | ||
2025-09-12 10:35 |
Interim Report
Half Year Financial Report 2025
|
English | 3.3 MB | ||
2025-09-12 10:34 |
Interim Report
Relazione finanziaria semestrale 2025
|
Italian | 3.4 MB | ||
2025-09-12 10:33 |
Report Publication Announcement
CS_Disponibilità Relazione Semestrale 2025 || Availability Half Year financial …
|
Italian | 269.4 KB | ||
2025-09-08 17:55 |
Earnings Release
PHN: The Board of Directors approved the results as of 30 June 2025
|
English | 443.8 KB | ||
2025-09-08 17:55 |
Earnings Release
PHN: il Consiglio di Amministrazione ha approvato i risultati al 30 giugno 2025
|
Italian | 370.0 KB | ||
2025-08-04 18:05 |
Regulatory News Service
PR PHARMANUTRA SPA - Sidevit B12 sales
|
English | 465.8 KB | ||
2025-08-04 18:04 |
Earnings Release
CS PHARMANUTRA SPA - Vendite Sidevit B12
|
Italian | 259.1 KB | ||
2025-06-03 08:00 |
Regulatory News Service
Pharmanutra: Lancio ApportAL Boost
|
Italian | 189.4 KB | ||
2025-06-03 08:00 |
Regulatory News Service
Pharmanutra: Launch of ApportAL Boost
|
English | 241.0 KB | ||
2025-05-27 10:47 |
Investor Presentation
MIDCAP Road Show - Paris
|
English | 3.4 MB | ||
2025-05-15 15:26 |
Registration Form
Statuto sociale aggiornato
|
Italian | 295.1 KB | ||
2025-05-15 15:25 |
Pre-Annual General Meeting Information
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
|
Italian | 9.4 MB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |